Literature DB >> 30036590

Baby-directed umbilical cord clamping: A feasibility study.

Douglas A Blank1, Shiraz Badurdeen2, C Omar F Kamlin3, Susan E Jacobs4, Marta Thio5, Jennifer A Dawson6, Stefan C Kane7, Alicia T Dennis8, Graeme R Polglase9, Stuart B Hooper10, Peter G Davis11.   

Abstract

INTRODUCTION: Over five percent of infants born worldwide will need help breathing after birth. Delayed cord clamping (DCC) has become the standard of care for vigorous infants. DCC in non-vigorous infants is uncommon because of logistical difficulties in providing effective resuscitation during DCC. In Baby-Directed Umbilical Cord Clamping (Baby-DUCC), the umbilical cord remains patent until the infant's lungs are exchanging gases. We conducted a feasibility study of the Baby-DUCC technique.
METHODS: We obtained antenatal consent from pregnant women to enroll infants born at ≥32 weeks. Vigorous infants received ≥2 min of DCC. If the infant received respiratory support, the umbilical cord was clamped ≥60 s after the colorimetric carbon dioxide detector turned yellow. Maternal uterotonic medication was administered after umbilical cord clamping. A paediatrician and researcher entered the sterile field to provide respiratory support during a cesarean birth. Maternal and infant outcomes in the delivery room and prior to hospital discharge were analysed.
RESULTS: Forty-four infants were enrolled, 23 delivered via cesarean section (8 unplanned) and 15 delivered vaginally (6 via instrumentation). Twelve infants were non-vigorous. ECG was the preferred method for recording HR. Two infants had a HR < 100 BPM. All HR values were >100 BPM by 80 s after birth. Median time to umbilical cord clamping was 150 and 138 s in vigorous and non-vigorous infants, respectively. Median maternal blood loss was 300 ml.
CONCLUSIONS: It is feasible to provide resuscitation to term and near-term infants during DCC, after both vaginal and cesarean births, clamping the umbilical cord only when the infant is physiologically ready.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cesarean; Delayed cord clamping; ECG; Heart rate; Newborn; Resuscitation; Uterotonic medication

Mesh:

Year:  2018        PMID: 30036590     DOI: 10.1016/j.resuscitation.2018.07.020

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  10 in total

Review 1.  Oxygen saturation and heart rate in healthy term and late preterm infants with delayed cord clamping.

Authors:  Inmaculada Lara-Cantón; Shiraz Badurdeen; Janneke Dekker; Peter Davis; Calum Roberts; Arjan Te Pas; Máximo Vento
Journal:  Pediatr Res       Date:  2022-01-07       Impact factor: 3.756

Review 2.  Toward greater nuance in delayed cord clamping.

Authors:  Laura Marrs; Susan Niermeyer
Journal:  Curr Opin Pediatr       Date:  2022-04-01       Impact factor: 2.856

3.  Physiologically based cord clamping for infants ≥32+0 weeks gestation: A randomised clinical trial and reference percentiles for heart rate and oxygen saturation for infants ≥35+0 weeks gestation.

Authors:  Shiraz Badurdeen; Peter G Davis; Stuart B Hooper; Susan Donath; Georgia A Santomartino; Alissa Heng; Diana Zannino; Monsurul Hoq; C Omar F Kamlin; Stefan C Kane; Anthony Woodward; Calum T Roberts; Graeme R Polglase; Douglas A Blank
Journal:  PLoS Med       Date:  2022-06-23       Impact factor: 11.613

4.  The Assisted Breathing before Cord Clamping (ABC) Study Protocol.

Authors:  Michael P Meyer; Elizabeth Nevill
Journal:  Children (Basel)       Date:  2021-04-26

5.  Transfusion or Timing: The Role of Blood Volume in Delayed Cord Clamping During the Cardiovascular Transition at Birth.

Authors:  Fiona J Stenning; Stuart B Hooper; Martin Kluckow; Kelly J Crossley; Andrew W Gill; Euan M Wallace; Arjan B Te Pas; Domenic LaRosa; Graeme R Polglase
Journal:  Front Pediatr       Date:  2019-10-09       Impact factor: 3.418

6.  Initiating resuscitation before umbilical cord clamping in infants with congenital diaphragmatic hernia: a pilot feasibility trial.

Authors:  Elizabeth E Foglia; Anne Ades; Holly L Hedrick; Natalie Rintoul; David A Munson; Julie Moldenhauer; Juliana Gebb; Bonnie Serletti; Aasma Chaudhary; Danielle D Weinberg; Natalie Napolitano; María Victoria Fraga; Sarah J Ratcliffe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2019-08-28       Impact factor: 5.747

7.  Resuscitation of Term Compromised and Asphyctic Newborns: Better with Intact Umbilical Cord?

Authors:  Friederike Ott; Angela Kribs; Patrick Stelzl; Ioannis Kyvernitakis; Michael Ehlen; Susanne Schmidtke; Tamina Rawnaq-Möllers; Werner Rath; Richard Berger; Holger Maul
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-06-23       Impact factor: 2.754

8.  Physiological-based cord clamping in very preterm infants: the Aeration, Breathing, Clamping 3 (ABC3) trial-study protocol for a multicentre randomised controlled trial.

Authors:  Ronny Knol; Emma Brouwer; Thomas van den Akker; Philip L J DeKoninck; Enrico Lopriore; Wes Onland; Marijn J Vermeulen; M Elske van den Akker-van Marle; Leti van Bodegom-Vos; Willem P de Boode; Anton H van Kaam; Irwin K M Reiss; Graeme R Polglase; G Jeroen Hutten; Sandra A Prins; Estelle E M Mulder; Christian V Hulzebos; Sam J van Sambeeck; Mayke E van der Putten; Inge A Zonnenberg; Stuart B Hooper; Arjan B Te Pas
Journal:  Trials       Date:  2022-10-01       Impact factor: 2.728

9.  Neonatal transitional support with intact umbilical cord in assisted vaginal deliveries: a quality-improvement cohort study.

Authors:  Elisabeth Sæther; Friedrich Reinhart-Van Gülpen; Christer Jensen; Tor Åge Myklebust; Beate Horsberg Eriksen
Journal:  BMC Pregnancy Childbirth       Date:  2020-08-27       Impact factor: 3.007

10.  Physiologic-Based Cord Clamping Maintains Core Temperature vs. Immediate Cord Clamping in Near-Term Lambs.

Authors:  Douglas A Blank; Kelly J Crossley; Aidan J Kashyap; Ryan J Hodges; Philip L J DeKoninck; Erin V McGillick; Karyn A Rodgers; Arjan B Te Pas; Stuart B Hooper; Graeme R Polglase
Journal:  Front Pediatr       Date:  2020-10-23       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.